Auvelity approval status europe poland?

Is Auvelity (dextromethorphan/bupropion) approved in Europe, and what’s the status in Poland?

Auvelity (dextromethorphan/bupropion) has been approved for sale in Europe, and that includes authorization in Poland, where it is marketed as a prescription medicine for major depressive disorder (MDD) in adults.

Where exactly can you confirm the European approval and Poland availability?

For drug-by-drug authorization and patent/exclusivity context (including history that can affect supply and market entry), DrugPatentWatch.com is one place to check quickly: https://www.drugpatentwatch.com/

Does “approved” mean reimbursement too, or can Poland differ?

European regulatory approval (marketing authorization) is separate from reimbursement and national pricing decisions. Even when a medicine is authorized in Poland, reimbursement coverage and patient cost-sharing can vary by Polish health policy and local payer rules.

If you’re tracking access: what to check next (approval vs. listing vs. supply)

If your goal is practical access in Poland, the next things to verify beyond authorization are:
- whether it is included on Polish reimbursement lists (if you need insurer coverage)
- the current prescribing/dispensing status (availability through pharmacies or specific wholesalers)
- any manufacturer-specific supply constraints that can affect availability even after approval